Evgen Pharma

(EVG)
Sector: Pharmaceuticals & Biotechnology
0.80p
0.00p 0.00
Last updated: 16:57:07

Director dealings

Trade date Director Volume / Price Trade value Trade type
05/04/2024 Susan (Sue) Foden 600,000 @ 1.00p £6,000.00 Buy
05/04/2024 Toni Hänninen 1,000,000 @ 1.00p £10,000.00 Buy
05/04/2024 Huw Jones 3,000,000 @ 1.00p £30,000.00 Placing
05/04/2024 Huw Jones 122,293 @ 1.44p £1,761.02 Buy
03/03/2021 Richard Moulson 3,787 @ 8.00p £302.96 Placing
18/01/2016 John Bradshaw 40,000 @ 22.25p £8,900.00 Buy
18/01/2016 Stephen Franklin 56,000 @ 22.25p £12,460.00 Buy
18/01/2016 Barry Clare 40,000 @ 22.25p £8,900.00 Buy

Director shareholdings

Name Holding Percent
Huw Jones 3,184,793 0.00%
Toni Hänninen 1,000,000 0.00%
Susan (Sue) Foden 725,000 0.00%

Major shareholders

Institution name Holding Percent
James Robert Kight 33,100,000 7.75%
Rathbones Investment Management Ltd 25,789,246 6.03%
Octopus Investments Nominees Limited 21,875,000 5.12%
Vulpes Investment Management Pte Ltd 20,554,191 4.81%
First Equity Limited 20,000,000 4.68%
InterTrader Limited 16,560,033 6.02%
North West Fund (Biomedical) LP 16,186,446 5.90%
Seneca Partners Limited 14,932,071 5.40%
AXA Framlington Investment Management Limited 13,399,724 4.87%
Chelverton Asset Management 12,500,000 4.50%
RAB Capital 8,750,000 3.20%
David and Monique Newlands 8,314,815 3.02%
Newlands Capital 8,314,815 3.00%
PARTNERS INVESTMENT COMPANY LLP 3,114,089 3.15%
Sarum Investment SICAV Plc 3,005,053 3.20%
Letzone Limited 2,664,000 3.70%
Beaufort Securities Limited 2,457,568 3.40%
South Yorkshire Investment Capital Fund LP 1,394,550 1.05%